Fatty acid elongase 7 catalyzes lipidome remodeling essential for human cytomegalovirus replication

Cell Reports

Volumn 10, Issue 8, 2015, Pages 1375-1385

  Purdy, John G ^a   Shenk, Thomas ^a   Rabinowitz, Joshua D ^a  

^a PRINCETON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME; FATTY ACID; FATTY ACID ELONGASE 7; GLUCOSE; LIPIDOME; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; PROTEIN UL38; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; UNCLASSIFIED DRUG; VIRUS PROTEIN; ACYLTRANSFERASE; FATTY ACID ELONGASES; SMALL INTERFERING RNA; SREBF1 PROTEIN, HUMAN; TARGET OF RAPAMYCIN KINASE;

ARTICLE; CATALYSIS; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; FATTY ACID ANALYSIS; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; LUNG FIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RNA ANALYSIS; UPREGULATION; VIRION; VIRUS PARTICLE; VIRUS REPLICATION; ANTAGONISTS AND INHIBITORS; BIOCATALYSIS; CELL LINE; CYTOMEGALOVIRUS; GENETICS; METABOLISM; PHYSIOLOGY; RNA INTERFERENCE;

HUMAN HERPESVIRUS 5;

ACETYLTRANSFERASES; BIOCATALYSIS; CELL LINE; CYTOMEGALOVIRUS; FATTY ACIDS; HUMANS; RNA INTERFERENCE; RNA, SMALL INTERFERING; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TOR SERINE-THREONINE KINASES; VIRAL PROTEINS; VIRION; VIRUS REPLICATION;

EID: 84924612242     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.02.003     Document Type: Article

References (64)

1. Alwine J.C. Modulation of host cell stress responses by human cytomegalovirus. Curr. Top. Microbiol. Immunol. 2008, 325:263-279.
2. Alwine J.C. The human cytomegalovirus assembly compartment: a masterpiece of viral manipulation of cellular processes that facilitates assembly and egress. PLoS Pathog. 2012, 8:e1002878.
3. Bissinger A.L., Sinzger C., Kaiserling E., Jahn G. Human cytomegalovirus as a direct pathogen: correlation of multiorgan involvement and cell distribution with clinical and pathological findings in a case of congenital inclusion disease. J.Med. Virol. 2002, 67:200-206.
4. Britt W. Manifestations of human cytomegalovirus infection: proposed mechanisms of acute and chronic disease. Curr. Top. Microbiol. Immunol. 2008, 325:417-470.
5. Buchkovich N.J., Maguire T.G., Yu Y., Paton A.W., Paton J.C., Alwine J.C. Human cytomegalovirus specifically controls the levels of the endoplasmic reticulum chaperone BiP/GRP78, which is required for virion assembly. J.Virol. 2008, 82:31-39.
6. Chambers J.W., Maguire T.G., Alwine J.C. Glutamine metabolism is essential for human cytomegalovirus infection. J.Virol. 2010, 84:1867-1873.
7. Clasquin M.F., Melamud E., Rabinowitz J.D. LC-MS data processing with MAVEN: a metabolomic analysis and visualization engine. Curr. Protoc. Bioinformatics 2012, Chapter 14:11.
8. Clippinger A.J., Alwine J.C. Dynein mediates the localization and activation of mTOR in normal and human cytomegalovirus-infected cells. Genes Dev. 2012, 26:2015-2026.
9. Cobbs C.S. Cytomegalovirus and brain tumor: epidemiology, biology and therapeutic aspects. Curr. Opin. Oncol. 2013, 25:682-688.
10. Cobbs C.S., Harkins L., Samanta M., Gillespie G.Y., Bharara S., King P.H., Nabors L.B., Cobbs C.G., Britt W.J. Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res. 2002, 62:3347-3350.
11. Deguil J., Pineau L., Rowland Snyder E.C., Dupont S., Beney L., Gil A., Frapper G., Ferreira T. Modulation of lipid-induced ER stress by fatty acid shape. Traffic 2011, 12:349-362.
12. Delgado T., Sanchez E.L., Camarda R., Lagunoff M. Global metabolic profiling of infection by an oncogenic virus: KSHV induces and requires lipogenesis for survival of latent infection. PLoS Pathog. 2012, 8:e1002866.
13. Gibson W. Structure and formation of the cytomegalovirus virion. Curr. Top. Microbiol. Immunol. 2008, 325:187-204.
14. Grady S.L., Purdy J.G., Rabinowitz J.D., Shenk T. Argininosuccinate synthetase 1 depletion produces a metabolic state conducive to herpes simplex virus 1 infection. Proc. Natl. Acad. Sci. USA 2013, 110:E5006-E5015.
15. Harkewicz R., Du H., Tong Z., Alkuraya H., Bedell M., Sun W., Wang X., Hsu Y.H., Esteve-Rudd J., Hughes G., et al. Essential role of ELOVL4 protein in very long chain fatty acid synthesis and retinal function. J.Biol. Chem. 2012, 287:11469-11480.
16. Heaton N.S., Perera R., Berger K.L., Khadka S., Lacount D.J., Kuhn R.J., Randall G. Dengue virus nonstructural protein 3 redistributes fatty acid synthase to sites of viral replication and increases cellular fatty acid synthesis. Proc. Natl. Acad. Sci. USA 2010, 107:17345-17350.
17. Jakobsson A., Westerberg R., Jacobsson A. Fatty acid elongases in mammals: their regulation and roles in metabolism. Prog. Lipid Res. 2006, 45:237-249.
18. Janssen R.J., Distelmaier F., Smeets R., Wijnhoven T., Østergaard E., Jaspers N.G., Raams A., Kemp S., Rodenburg R.J., Willems P.H., et al. Contiguous gene deletion of ELOVL7, ERCC8 and NDUFAF2 in a patient with a fatal multisystem disorder. Hum. Mol. Genet. 2009, 18:3365-3374.
19. Kamphorst J.J., Fan J., Lu W., White E., Rabinowitz J.D. Liquid chromatography-high resolution mass spectrometry analysis of fatty acid metabolism. Anal. Chem. 2011, 83:9114-9122.
20. Karaskov E., Scott C., Zhang L., Teodoro T., Ravazzola M., Volchuk A. Chronic palmitate but not oleate exposure induces endoplasmic reticulum stress, which may contribute to INS-1 pancreatic beta-cell apoptosis. Endocrinology 2006, 147:3398-3407.
21. Kitazawa H., Miyamoto Y., Shimamura K., Nagumo A., Tokita S. Development of a high-density assay for long-chain fatty acyl-CoA elongases. Lipids 2009, 44:765-773.
22. Koyuncu E., Purdy J.G., Rabinowitz J.D., Shenk T. Saturated very long chain fatty acids are required for the production of infectious human cytomegalovirus progeny. PLoS Pathog. 2013, 9:e1003333.
23. Kudchodkar S.B., Yu Y., Maguire T.G., Alwine J.C. Human cytomegalovirus infection induces rapamycin-insensitive phosphorylation of downstream effectors of mTOR kinase. J.Virol. 2004, 78:11030-11039.
24. Kudchodkar S.B., Yu Y., Maguire T.G., Alwine J.C. Human cytomegalovirus infection alters the substrate specificities and rapamycin sensitivities of raptor- and rictor-containing complexes. Proc. Natl. Acad. Sci. USA 2006, 103:14182-14187.
25. Laplante M., Sabatini D.M. An emerging role of mTOR in lipid biosynthesis. Curr. Biol. 2009, 19:R1046-R1052.
26. Leonard A.E., Kelder B., Bobik E.G., Chuang L.T., Lewis C.J., Kopchick J.J., Mukerji P., Huang Y.S. Identification and expression of mammalian long-chain PUFA elongation enzymes. Lipids 2002, 37:733-740.
27. Lewis C.A., Griffiths B., Santos C.R., Pende M., Schulze A. Regulation of the SREBP transcription factors by mTORC1. Biochem. Soc. Trans. 2011, 39:495-499.
28. Li W., Sandhoff R., Kono M., Zerfas P., Hoffmann V., Ding B.C., Proia R.L., Deng C.X. Depletion of ceramides with very long chain fatty acids causes defective skin permeability barrier function, and neonatal lethality in ELOVL4 deficient mice. Int. J. Biol. Sci. 2007, 3:120-128.
29. Liu Q., Wang J., Kang S.A., Thoreen C.C., Hur W., Ahmed T., Sabatini D.M., Gray N.S. Discovery of 9-(6-aminopyridin-3-yl)-1-(3-(trifluoromethyl)phenyl)benzo[h][1,6]naphthyridin-2(1H)-one (Torin2) as a potent, selective, and orally available mammalian target of rapamycin (mTOR) inhibitor for treatment of cancer. J.Med. Chem. 2011, 54:1473-1480.
30. Liu S.T., Sharon-Friling R., Ivanova P., Milne S.B., Myers D.S., Rabinowitz J.D., Brown H.A., Shenk T. Synaptic vesicle-like lipidome of human cytomegalovirus virions reveals a role for SNARE machinery in virion egress. Proc. Natl. Acad. Sci. USA 2011, 108:12869-12874.
31. Mamane Y., Petroulakis E., LeBacquer O., Sonenberg N. mTOR, translation initiation and cancer. Oncogene 2006, 25:6416-6422.
32. Melamud E., Vastag L., Rabinowitz J.D. Metabolomic analysis and visualization engine for LC-MS data. Anal. Chem. 2010, 82:9818-9826.
33. Cytomegaloviruses 2007, Lippincott, Williams and Wilkins, Philadelphia, PA. E.S. Mocarski, T. Shenk, R.F. Pass (Eds.).
34. Moon Y.A., Shah N.A., Mohapatra S., Warrington J.A., Horton J.D. Identification of a mammalian long chain fatty acyl elongase regulated by sterol regulatory element-binding proteins. J.Biol. Chem. 2001, 276:45358-45366.
35. Moorman N.J., Shenk T. Rapamycin-resistant mTORC1 kinase activity is required for herpesvirus replication. J.Virol. 2010, 84:5260-5269.
36. Moorman N.J., Cristea I.M., Terhune S.S., Rout M.P., Chait B.T., Shenk T. Human cytomegalovirus protein UL38 inhibits host cell stress responses by antagonizing the tuberous sclerosis protein complex. Cell Host Microbe 2008, 3:253-262.
37. Moser T.S., Schieffer D., Cherry S. AMP-activated kinase restricts Rift Valley fever virus infection by inhibiting fatty acid synthesis. PLoS Pathog. 2012, 8:e1002661.
38. Moss P. The emerging role of cytomegalovirus in driving immune senescence: a novel therapeutic opportunity for improving health in the elderly. Curr. Opin. Immunol. 2010, 22:529-534.
39. Munger J., Bajad S.U., Coller H.A., Shenk T., Rabinowitz J.D. Dynamics of the cellular metabolome during human cytomegalovirus infection. PLoS Pathog. 2006, 2:e132.
40. Munger J., Bennett B.D., Parikh A., Feng X.J., McArdle J., Rabitz H.A., Shenk T., Rabinowitz J.D. Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy. Nat. Biotechnol. 2008, 26:1179-1186.
41. Nasheri N., Joyce M., Rouleau Y., Yang P., Yao S., Tyrrell D.L., Pezacki J.P. Modulation of fatty acid synthase enzyme activity and expression during hepatitis C virus replication. Chem. Biol. 2013, 20:570-582.
42. Ofman R., Dijkstra I.M., van Roermund C.W., Burger N., Turkenburg M., van Cruchten A., van Engen C.E., Wanders R.J., Kemp S. The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy. EMBO Mol. Med. 2010, 2:90-97.
43. Ohno Y., Suto S., Yamanaka M., Mizutani Y., Mitsutake S., Igarashi Y., Sassa T., Kihara A. ELOVL1 production of C24 acyl-CoAs is linked to C24 sphingolipid synthesis. Proc. Natl. Acad. Sci. USA 2010, 107:18439-18444.
44. Petersen J., Drake M.J., Bruce E.A., Riblett A.M., Didigu C.A., Wilen C.B., Malani N., Male F., Lee F.H., Bushman F.D., et al. The major cellular sterol regulatory pathway is required for Andes virus infection. PLoS Pathog. 2014, 10:e1003911.
45. Pineau L., Colas J., Dupont S., Beney L., Fleurat-Lessard P., Berjeaud J.M., Bergès T., Ferreira T. Lipid-induced ER stress: synergistic effects of sterols and saturated fatty acids. Traffic 2009, 10:673-690.
46. Qian Z., Xuan B., Gualberto N., Yu D. The human cytomegalovirus protein pUL38 suppresses endoplasmic reticulum stress-mediated cell death independently of its ability to induce mTORC1 activation. J.Virol. 2011, 85:9103-9113.
47. Rabinowitz J.D., Purdy J.G., Vastag L., Shenk T., Koyuncu E. Metabolomics in drug target discovery. Cold Spring Harb. Symp. Quant. Biol. 2011, 76:235-246.
48. Sanchez V., Dong J.J. Alteration of lipid metabolism in cells infected with human cytomegalovirus. Virology 2010, 404:71-77.
49. Savaryn J.P., Reitsma J.M., Bigley T.M., Halligan B.D., Qian Z., Yu D., Terhune S.S. Human cytomegalovirus pUL29/28 and pUL38 repression of p53-regulated p21CIP1 and caspase 1 promoters during infection. J.Virol. 2013, 87:2463-2474.
50. Seo J.Y., Cresswell P. Viperin regulates cellular lipid metabolism during human cytomegalovirus infection. PLoS Pathog. 2013, 9:e1003497.
51. Spencer C.M., Schafer X.L., Moorman N.J., Munger J. Human cytomegalovirus induces the activity and expression of acetyl-coenzyme A carboxylase, a fatty acid biosynthetic enzyme whose inhibition attenuates viral replication. J.Virol. 2011, 85:5814-5824.
52. Streblow D.N., Dumortier J., Moses A.V., Orloff S.L., Nelson J.A. Mechanisms of cytomegalovirus-accelerated vascular disease: induction of paracrine factors that promote angiogenesis and wound healing. Curr. Top. Microbiol. Immunol. 2008, 325:397-415.
53. Tamura K., Makino A., Hullin-Matsuda F., Kobayashi T., Furihata M., Chung S., Ashida S., Miki T., Fujioka T., Shuin T., et al. Novel lipogenic enzyme ELOVL7 is involved in prostate cancer growth through saturated long-chain fatty acid metabolism. Cancer Res. 2009, 69:8133-8140.
54. Terhune S., Torigoi E., Moorman N., Silva M., Qian Z., Shenk T., Yu D. Human cytomegalovirus UL38 protein blocks apoptosis. J.Virol. 2007, 81:3109-3123.
55. Terry L.J., Vastag L., Rabinowitz J.D., Shenk T. Human kinome profiling identifies a requirement for AMP-activated protein kinase during human cytomegalovirus infection. Proc. Natl. Acad. Sci. USA 2012, 109:3071-3076.
56. Vastag L., Koyuncu E., Grady S.L., Shenk T.E., Rabinowitz J.D. Divergent effects of human cytomegalovirus and herpes simplex virus-1 on cellular metabolism. PLoS Pathog. 2011, 7:e1002124.
57. Wang Y., Botolin D., Xu J., Christian B., Mitchell E., Jayaprakasam B., Nair M.G., Peters J.M., Busik J.V., Olson L.K., Jump D.B. Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity. J.Lipid Res. 2006, 47:2028-2041.
58. Womack A., Shenk T. Human cytomegalovirus tegument protein pUL71 is required for efficient virion egress. MBio 2010, 1:e00282-e00310.
59. Ye J., DeBose-Boyd R.A. Regulation of cholesterol and fatty acid synthesis. Cold Spring Harb. Perspect. Biol. 2011, 3. pii: a004754.
60. Yu D., Smith G.A., Enquist L.W., Shenk T. Construction of a self-excisable bacterial artificial chromosome containing the human cytomegalovirus genome and mutagenesis of the diploid TRL/IRL13 gene. J.Virol. 2002, 76:2316-2328.
61. Yu Y., Maguire T.G., Alwine J.C. Human cytomegalovirus activates glucose transporter 4 expression to increase glucose uptake during infection. J.Virol. 2011, 85:1573-1580.
62. Yu Y., Maguire T.G., Alwine J.C. Human cytomegalovirus infection induces adipocyte-like lipogenesis through activation of sterol regulatory element binding protein 1. J.Virol. 2012, 86:2942-2949.
63. Yu Y., Pierciey F.J., Maguire T.G., Alwine J.C. PKR-like endoplasmic reticulum kinase is necessary for lipogenic activation during HCMV infection. PLoS Pathog. 2013, 9:e1003266.
64. Yu Y., Maguire T.G., Alwine J.C. ChREBP, a glucose-responsive transcriptional factor, enhances glucose metabolism to support biosynthesis in human cytomegalovirus-infected cells. Proc. Natl. Acad. Sci. USA 2014, 111:1951-1956.